---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-045106"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2025-10-15T23:59:59+00:00"
generated_at: "2026-05-17T03:40:51.937333+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BD reports prelim Q4 rev $5.9B (+8.3%); CFO DelOrefice to depart Dec 5; Roque interim CFO

## Summary
- Preliminary Q4 revenue ~$5.9B, up 8.3% reported, 3.9% organic; FY revenue ~$21.8B, up 8.2% reported, 2.9% organic.
- CFO Chris DelOrefice resigns effective Dec 5, 2025 to pursue new opportunity; departure not due to disagreement.
- Vitor Roque, SVP Finance, named interim CFO effective upon DelOrefice's departure; permanent search underway.
- FY2025 adjusted diluted EPS expected at or above midpoint of prior guidance.
- Headwinds in Pharma Systems vaccines and Biosciences academic/govt research; strong growth in Interventional, APM, Med Delivery Solutions.

## SEC filing metadata
- accession: 0001628280-25-045106
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2025-10-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000162828025045106/0001628280-25-045106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000162828025045106/bdx-20251009.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-045106
- JSON: https://secwatch.observer/filing/0001628280-25-045106.json
- Plain text: https://secwatch.observer/filing/0001628280-25-045106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.